?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
July 28, 2022
signalgroup
Hillel Cohen Member Spotlight
News
July 21, 2022
signalgroup
The Biosimilars Forum Launches Updated Website Content
News
July 14, 2022
signalgroup
Rebecca Mandell Member Spotlight
News
June 22, 2022
signalgroup
The Biosimilars Forum Welcomes Legislation to Hold PBMs Accountable for Unfair Practices
News
June 21, 2022
signalgroup
Rachel Turow Member Spotlight
News
June 16, 2022
signalgroup
Brian Lehman Member Spotlight
News
June 7, 2022
signalgroup
The Biosimilars Forum Commends FTC for Probe into PBMs
News
June 6, 2022
signalgroup
Biosimilars Forum Welcomes Fresenius Kabi
News
April 6, 2022
signalgroup
Biosimilars Forum Letter to Senate HELP Committee on FDA User Fee Agreements
News
March 31, 2022
signalgroup
HHS Inspector General Report: Biosimilars Could Generate Significant Medicare Part D Savings
Prev page
04
05
06
07
08
Next page